Ovarian Mass-Differentiating Benign From Malignant. Why the International Ovarian Tumour Analysis Rules Should Be Implemented in Australasia

Australasian Journal of Ultrasound in Medicine
doi 10.1002/ajum.12108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Is It Time to Implement the International Ovarian Tumour Analysis Rules in Australasia?

Australasian Journal of Ultrasound in Medicine
2017English

Glutathione S-Transferase Activity and Isoenzyme Composition in Benign Ovarian Tumours, Untreated Malignant Ovarian Tumours, and Malignant Ovarian Tumours After Platinum/Cyclophosphamide Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1992English

Validity of Ultrasound in Detecting Benign and Malignant Ovarian Cysts

Annals of the College of Medicine, Mosul
2013English

Glutathione S-Transferase Expression in Benign and Malignant Ovarian Tumours

British Journal of Cancer
Cancer ResearchOncology
1993English

International Ovarian Tumor Analysis Simple Rules: The Essential Starting Point for Optimal Management

Australasian Journal of Ultrasound in Medicine
2019English

Why Deep Space Habitats Should Be Different From the International Space Station

2016English

Differentiating Benign From Malignant Cervical Lymph Nodes With Sonoelastography

International Journal of Medical Imaging
2017English

Mutant Epidermal Growth Factor Receptor in Benign, Borderline, and Malignant Ovarian Tumors

Clinical Cancer Research
Cancer ResearchOncology
2008English

P11.01: Diagnostic Accuracy of IOTA ADNEX and IOTA LR2 Model Compared With Subjective Assessment ( SA) in Differentiating Benign and Malignant Ovarian Masses

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy